Effects of FR167653 on pulmonary ischemia-reperfusion injury: Administration timing

Transplantation Proceedings

Volumn 31, Issue 5, 1999, Pages 1935-1936

  Takeyoshi, I ^a   Otani, Y ^a   Koibuchi, Y ^a   Yokoe, T ^a   Iino, Y ^a   Matsumoto, K ^b   Muramoto, M ^c   Satoh, S ^c   Morishita, Y ^c  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; CYTOKINE; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN SATURATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ISCHEMIA; LUNG TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ANIMALS; INTERLEUKIN-1; LUNG DISEASES; MALE; PYRAZOLES; PYRIDINES; RATS; RATS, WISTAR; REPERFUSION INJURY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032810423     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00215-8     Document Type: Article

References (11)

1. Kamoshita N., Takeyoshi I., Ohwada S., et al. J Heart Lung Transplant. 16:1997;1062.
2. Yamamoto N., Sakai F., Yamazaki H., et al. Eur J Pharmacol. 314:1996;137.
3. Otani Y, Takeyoshi I, Koibuchi Y, et al: J Heart Lung Transplant (in press).
4. Sundaresan S., Alevy Y.G., Steward N., et al. J Heart Lung Transplant. 14:1995;512.
5. Parks D.A., Bulkley G.B., Granger D.N., et al. Gastroenterology. 82:1982;9.
6. Granger D.N., Rutili G., McCord J.M. Gastroenterology. 81:1981;22.
7. Mozes T., Braquet P., Filep J. Am J Physiol. 257:1989;R872.
8. Welbourn C.R., Goldman G., Paterson I.S., et al. Br J Surg. 78:1991;651.
9. Yamamoto N., Sakai F., Yamazaki H., et al. Eur J Pharmacol. 327:1997;169.
10. Kobayashi J., Takeyoshi I., Ohwada S., et al. Hepatology. 28:1998;459.
11. Lee J.C., Laydon J.T., McDonnell P.C., et al. Nature. 372:1994;739.